| Authors: |
Small JC; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States.; Chemistry Biology Program, Harvard Medical School, Boston, Massachusetts 02115, United States., Joblin-Mills A; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, Victoria University of Wellington, Wellington 6140, New Zealand., Carbone K; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States., Kost-Alimova M; Center for the Development of Therapeutics, Broad Institute, Cambridge, Massachusetts 02142, United States., Ayukawa K; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States.; JT Pharmaceuticals Inc., Takatsuki 569-1125, Osaka, Japan., Khodier C; Center for the Development of Therapeutics, Broad Institute, Cambridge, Massachusetts 02142, United States., Dancik V; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States., Clemons PA; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States., Munkacsi AB; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, Victoria University of Wellington, Wellington 6140, New Zealand., Wagner BK; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States. |